SUGEMALIMAB

UNII: 90IQR2I6TR
Preferred Substance Name: SUGEMALIMAB

2256084-03-2
ANTI-PD-L1 MONOCLONAL ANTIBODY CS1001
ANTI-PD-L1 MONOCLONAL ANTIBODY WBP 3155
CS1001
CS-1001
IMMUNOGLOBULIN G4 (228-PROLINE) (ANTI-(HUMAN PROGRAMMED DEATH-LIGAND 1)) (HUMAN MONOCLONAL CS1001 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL CS1001 .LAMBDA.-CHAIN, DIMER
SUGEMALIMAB [INN]
SUGEMALIMAB [WHO-DD]
WBP315
WBP-315

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

SUGEMALIMAB

Synonyms and Mappings

Resources

Note